Fulgent Genetics, Inc. (FLGT) Tops Q3 EPS by 80c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $4.05, $0.80 better than the analyst estimate of $3.25. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $264 million.

GUIDANCE:

Fulgent Genetics, Inc. sees FY2021 revenue of $930 million, versus the consensus of $948 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
• Worried the AI trade has gone too far? Evercore likes these 4 stocks